Evaluate the applicability of a robotic soft esophagus (ROSE) in assessing the swallowability of opioid drugs under physiological parameters mimicking normal and pathological conditions.

Ended Definitive Contract Awarded Last action

Contract number
75F40121C00132
Awardee
Awarding agency
Obligated
$298,583

Award facts

Opportunity
Contract value 100% obligated
$298,583.09 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Basic Research
Pricing
Cost No Fee
Place of performance
El Cajon, CA 92019, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00005 -$11,394
Other Administrative Action P00004 · NCE modification -- evaluate the applicability of a robotic soft esophagus (ROSE) in assessing the swallowability of opioid drugs under physiological parameters… $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $309,977

About this award

The U.S. Food and Drug Administration (FDA) awarded a $298,583.09 definitive contract to The University of Auckland Research Office Division, a state-controlled institution of higher learning based in New Zealand, to evaluate the applicability of a robotic soft esophagus (ROSE) device in assessing the swallowability of opioid drugs under normal and pathological conditions. This contract was issued under the FDA's Broad Agency Announcement for Advanced Regulatory Science, which solicits research and development proposals to support the agency's regulatory science and innovation goals. The contract does not have a set-aside designation, indicating The University of Auckland's ability to compete for this open federal opportunity. This award demonstrates the FDA's collaboration with international research institutions to develop innovative tools and methodologies that can contribute to the agency's mission of protecting public health.

Quick answers

Who was awarded contract 75F40121C00132?

75F40121C00132 was awarded to The University Of Auckland by Food and Drug Administration (Department of Health and Human Services) on September 22, 2021.

How much is contract 75F40121C00132 worth?

The government has obligated $298,583 on 75F40121C00132.

Was contract 75F40121C00132 competed?

The extent of competition for 75F40121C00132 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award